OP Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136M Sell
113,526
-53,087
-32% -$54.2M 1.45% 13
2026
Q1
$153M Buy
166,613
+53,187
+47% +$53.9M 1.54% 12
2025
Q4
$122M Buy
113,426
+16,895
+18% +$16.2M 1.45% 12
2025
Q3
$73.7M Buy
96,531
+6,296
+7% +$4.69M 0.95% 15
2025
Q2
$70.3M Buy
90,235
+1,184
+1% +$920K 1.01% 15
2025
Q1
$73.5M Buy
+89,051
New +$74.1M 1.2% 14

Other funds holding LLY

OP Asset Management's LLY Position: Q2 2026 in Review

OP Asset Management reduced its Eli Lilly (LLY) stake by 32% in Q2 2026, selling an estimated $54.2M and leaving 113,526 shares worth $136M. The position accounts for 1.45% of the portfolio, ranked #13.

OP Asset Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $153M in Q1 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • OP Asset Management held 113,526 shares of Eli Lilly worth $136M as of Q2 2026.
  • OP Asset Management sold 53,087 Eli Lilly shares in Q2 2026, an estimated $54.2M.
  • Eli Lilly made up 1.45% of OP Asset Management's portfolio in Q2 2026, its #13 holding.
  • OP Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Eli Lilly position peaked at $153M in Q1 2026.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.